ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Glenmark Pharmaceuticals Limited Complete list of announcements declared & dividend announcements by Glenmark Pharmaceuticals Limited GLENMARK

Glenmark Pharmaceuticals Limited GLENMARK listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Glenmark Pharmaceuticals Limited GLENMARK

Company Announcement
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory action/ inspection
Announcement as on 02 April 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2026, titled "Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS in the U.S., Significantly Expand
Announcement as on 02 April 2026

Company Announcement
Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325.
Announcement as on 23 March 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Glenmark Pharmaceuticals Launches GLIPIQ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly trea
Announcement as on 23 March 2026

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 16, 2026, titled "Glenmark Pharmaceuticals Inc., USA to launch
Announcement as on 16 March 2026

Announcements by Glenmark Pharmaceuticals Limited first page | Next page |

GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals

Moving Averages for Glenmark Pharmaceuticals Limited

  • 5Day Average: 2132.72
  • 12Day Average: 2136.13
  • 20Day Average: 2147.49
  • 50Day Average: 2063.4
  • 100Day Average: 2011.06
  • 150Day Average: 1993.21
  • 200Day Average: 1983.04

GLENMARK Indicators & signals

Indicator MACD (12,26,9)

2130.66, 2119.14, 24.08
Indicator MACD is in positive zone

Indicator ADX (14)

9.82, 21.65, 26.36
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Thu Apr 2026 2091.80 1966.50 to 2098.40 -0.44% 1.37 times
01 Wed Apr 2026 2101.10 2085.00 to 2238.40 -1.44% 1.43 times
30 Mon Mar 2026 2131.70 2108.70 to 2170.80 -1.79% 1.69 times
27 Fri Mar 2026 2170.50 2146.60 to 2188.40 0.09% 1.05 times
25 Wed Mar 2026 2168.50 2102.40 to 2179.70 3.47% 0.63 times
24 Tue Mar 2026 2095.70 2078.30 to 2137.10 0.32% 0.76 times
23 Mon Mar 2026 2089.00 2079.90 to 2170.00 -4.18% 0.58 times
20 Fri Mar 2026 2180.10 2110.10 to 2190.90 3.94% 0.84 times
19 Thu Mar 2026 2097.50 2087.40 to 2176.60 -4.06% 0.66 times
18 Wed Mar 2026 2186.30 2143.10 to 2237.60 1.88% 1.25 times
17 Tue Mar 2026 2145.90 2136.00 to 2184.70 -1.36% 1.09 times
16 Mon Mar 2026 2175.40 2145.00 to 2214.80 0.22% 0.75 times

Videos related to: GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

 

Back to top